| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.503 | 19.698 | 87.960 | 31.672 | 116 | 40.548 | 50.136 | 5.235 | 3.263 | 1.132 |
| Total Income - EUR | 29.511 | 19.698 | 87.966 | 31.672 | 116 | 40.549 | 50.430 | 5.235 | 3.263 | 4.475 |
| Total Expenses - EUR | 15.351 | 24.595 | 19.261 | 20.926 | 22.064 | 24.160 | 22.269 | 21.739 | 17.859 | 18.488 |
| Gross Profit/Loss - EUR | 14.160 | -4.897 | 68.706 | 10.746 | -21.948 | 16.390 | 28.161 | -16.504 | -14.597 | -14.013 |
| Net Profit/Loss - EUR | 13.275 | -5.291 | 66.256 | 10.050 | -21.951 | 16.007 | 27.671 | -16.620 | -14.597 | -14.013 |
| Employees | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Femisana Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 29.978 | 25.127 | 18.243 | 11.854 | 8.587 | 5.863 | 36.761 | 29.124 | 21.404 | 13.695 |
| Current Assets | 7.231 | 1.850 | 111.292 | 119.030 | 73.213 | 77.843 | 82.333 | 52.215 | 39.420 | 26.455 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.422 | 311 | 102.318 | 105.818 | 70.078 | 71.903 | 76.676 | 50.269 | 36.408 | 24.526 |
| Cash | 5.809 | 1.539 | 8.974 | 13.212 | 3.135 | 5.940 | 5.657 | 1.946 | 3.012 | 1.929 |
| Shareholders Funds | 16.184 | 10.727 | 76.802 | 85.443 | 50.746 | 65.791 | 76.048 | 59.664 | 44.886 | 30.622 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 21.025 | 16.250 | 52.732 | 45.441 | 31.054 | 17.914 | 43.046 | 21.675 | 15.938 | 9.528 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Femisana Medical Srl